-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Insulet, Lowers Price Target to $210

Benzinga·07/13/2026 16:23:08
Listen to the news
Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $219 to $210.